Lupin, Glenmark and Sun Pharma recall various drugs from the US
The recall has been initiated by Lupin. The recall is for specific lots due to presence of particulate matter
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Wockhardt receives US FDA approval for leukemia drug
The drug stops cancer cells from growing and is indicated for treating cancers like leukemia and some gastro-intestinal tumors
BMA commemorates 65 years by launching a slew of new initiatives
Two key programmes, The 10X Scale-Up Conclave・and 'Innothon', will be undertaken to commemorate the event
New growth tonic for Indian pharma industry
Rishabh Bindlish, MD - AAPAC Life Sciences Lead, Accenture Strategy, advises that pharma companies need to tighten their belts…
Almac Group extends personalised cancer vaccine production facilities
Expands Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities
DRL gets four observations from US FDA for Andhra plant
The audit of DRL's Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by US FDA was recently completed
Zydus Cadila gets US FDA nod for glaucoma drug
The capsules will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad
Amgen’s postmenopausal osteoporosis drug wins FDA panel backing
The drug, Evenity, helps reduce the risk of fracture by increasing bone formation and inhibiting break down of bone minerals
Abbott to acquire Cephea Valve Technologies
Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart…
Merck welcomes ten new startups to its innovation centre
The ten selected startups will join the Merck Accelerator for the programme’s three-month duration